Research Site

Munich, Bavaria 81825

1 studies enrolling now · 10 studies all time

What they study most

Asthma, COPD, Chronic Obstructive Pulmonary Disease, Hepatobiliary Cancers, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Relapsing Forms of Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis, Supranuclear Palsy, Progressive, Systemic Lupus Erythematosus

Studies at this site

• Observational Study Protocol: LIVER-R — Recruiting now
• Observational Study of Obstructive Lung Disease (NOVELTY) — Completed
• Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS) — Completed
• Dimethyl Fumarate (DMF) Observational Study — Completed
• Plegridy Observational Program — Completed
• Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) — Stopped early
• Study of BIIB092 in Participants With Progressive Supranuclear Palsy — Stopped early
• Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) — Completed
• Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab — Stopped early
• A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis — Stopped early